Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Greenstone Biosciences is a biotech innovator based in Stanford Research Park, specializing in New Approach Methods (NAMs) and AI-driven technologies to enhance drug discovery. The company focuses on reducing reliance on animal testing by utilizing human iPSC-based models and advanced AI algorithms to accelerate the development of safer and more effective therapies.
Claim this profile to keep your information accurate and add what's missing.
Human-induced pluripotent stem cell (hiPSC) models for disease modeling and drug discovery.
3D organ-like tissue models derived from iPSCs that replicate real organ structure and function.
Services that utilize advanced screening methods to identify potential drug candidates rapidly.
Innovative platform for simulating clinical trials using patient-derived models.
Assay for assessing cardiac toxicity of drug candidates.
Greenstone Biosciences is a biotech company focused on revolutionizing drug discovery through innovative human-relevant technologies and AI-driven methods.
We offer a range of services including iPSC-derived cell models, organoid assays, high-throughput drug discovery, and toxicity screening.
Our technology utilizes human iPSC-based models and organoids that provide more relevant biological insights compared to traditional animal models.
We are based in Stanford Research Park.
Our services are designed for pharmaceutical companies, academic researchers, and institutions involved in drug discovery and development.